Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$31.57
At close: Jul 9, 4:00 PM EDT
$31.57
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
QuidelOrtho Analyst Ratings and Price Targets | NASDAQ:QDEL | Benzinga
QuidelOrtho Corp has a consensus price target of $52.56 based on the ratings of 10 analysts. The high is $86 issued by UBS on October 14, 2022. The low is $25 issued by JP Morgan on April 21, 2025. The 3 most-recent analyst ratings were released by UBS, Jefferies, and JP Morgan on May 8, 2025, May 8, 2025, and April 21, 2025, respectively. With an average price target of $32.67 between UBS, Jefferies, and JP Morgan, there's an implied 3.47% upside for QuidelOrtho Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Jefferies
JP Morgan
RBC Capital
UBS
1calculated from analyst ratings
Analyst Ratings for QuidelOrtho
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/08/2025 | Buy Now | -8.14% | UBS | Lu Li13% | $45 → $29 | Maintains | Neutral | Get Alert |
| 05/08/2025 | Buy Now | 39.37% | Jefferies | Tycho Peterson83% | → $44 | Upgrade | Hold → Buy | Get Alert |
| 04/21/2025 | Buy Now | -20.81% | JP Morgan | Casey Woodring29% | $38 → $25 | Maintains | Underweight | Get Alert |
| 02/13/2025 | Buy Now | 93.22% | RBC Capital | Conor McNamara37% | $64 → $61 | Maintains | Outperform | Get Alert |
| 02/13/2025 | Buy Now | 42.54% | UBS | John Sourbeer34% | $43 → $45 | Maintains | Neutral | Get Alert |
| 12/11/2024 | Buy Now | 58.38% | Citigroup | Patrick Donnelly79% | $44 → $50 | Upgrade | Neutral → Buy | Get Alert |
| 12/10/2024 | Buy Now | 36.21% | Jefferies | Tycho Peterson83% | → $43 | Initiates | → Hold | Get Alert |
| 11/08/2024 | Buy Now | 36.21% | UBS | John Sourbeer34% | $50 → $43 | Maintains | Neutral | Get Alert |
| 09/19/2024 | Buy Now | 58.38% | UBS | John Sourbeer34% | $42 → $50 | Upgrade | Sell → Neutral | Get Alert |
| 09/05/2024 | Buy Now | 80.55% | Craig-Hallum | Alexander Nowak53% | $40 → $57 | Upgrade | Hold → Buy | Get Alert |
| 08/16/2024 | Buy Now | 93.22% | RBC Capital | Conor McNamara37% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2024 | Buy Now | 93.22% | RBC Capital | Conor McNamara37% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2024 | Buy Now | 115.39% | RBC Capital | Conor McNamara37% | $81 → $68 | Maintains | Outperform | Get Alert |
| 03/04/2024 | Buy Now | 33.04% | UBS | John Sourbeer34% | $70 → $42 | Downgrade | Neutral → Sell | Get Alert |
| 02/14/2024 | Buy Now | — | Craig-Hallum | Alexander Nowak53% | — | Downgrade | Buy → Hold | Get Alert |
| 02/14/2024 | Buy Now | 156.57% | RBC Capital | Conor McNamara37% | $130 → $81 | Maintains | Outperform | Get Alert |
| 02/14/2024 | Buy Now | 140.73% | Raymond James | Andrew Cooper54% | $100 → $76 | Downgrade | Strong Buy → Outperform | Get Alert |
| 02/14/2024 | Buy Now | — | William Blair | Andrew Brackmann29% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/14/2024 | Buy Now | 17.2% | JP Morgan | Casey Woodring29% | $66 → $37 | Downgrade | Neutral → Underweight | Get Alert |
| 12/21/2023 | Buy Now | 311.78% | RBC Capital | Conor McNamara37% | $140 → $130 | Maintains | Outperform | Get Alert |
| 12/11/2023 | Buy Now | 128.06% | Citigroup | Patrick Donnelly79% | $95 → $72 | Downgrade | Buy → Neutral | Get Alert |
| 11/02/2023 | Buy Now | 216.76% | Raymond James | Andrew Cooper54% | $110 → $100 | Maintains | Strong Buy | Get Alert |
| 09/19/2023 | Buy Now | 343.46% | RBC Capital | Conor McNamara37% | → $140 | Reiterates | Outperform → Outperform | Get Alert |
| 08/15/2023 | Buy Now | 248.43% | Raymond James | Andrew Cooper54% | $130 → $110 | Maintains | Strong Buy | Get Alert |
| 08/09/2023 | Buy Now | 169.24% | JP Morgan | Casey Woodring29% | $91 → $85 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | 330.79% | RBC Capital | Conor McNamara37% | → $136 | Reiterates | Outperform → Outperform | Get Alert |
| 05/04/2023 | Buy Now | 321.29% | RBC Capital | Conor McNamara37% | $130 → $133 | Maintains | Outperform | Get Alert |
| 02/16/2023 | Buy Now | 330.79% | RBC Capital | Conor McNamara37% | $125 → $136 | Maintains | Outperform | Get Alert |
| 02/16/2023 | Buy Now | 311.78% | Raymond James | Andrew Cooper54% | $136 → $130 | Maintains | Strong Buy | Get Alert |
| 12/12/2022 | Buy Now | 295.95% | Citigroup | Patrick Donnelly79% | $90 → $125 | Upgrade | Neutral → Buy | Get Alert |
| 12/07/2022 | Buy Now | 295.95% | RBC Capital | Conor McNamara37% | → $125 | Initiates | → Outperform | Get Alert |
| 11/03/2022 | Buy Now | 194.58% | JP Morgan | Casey Woodring29% | $100 → $93 | Maintains | Neutral | Get Alert |
| 10/14/2022 | Buy Now | 172.41% | UBS | Elizabeth Garcia71% | → $86 | Upgrade | Sell → Neutral | Get Alert |
| 09/19/2022 | Buy Now | 185.08% | Citigroup | Patrick Donnelly79% | → $90 | Initiates | → Neutral | Get Alert |
| 07/20/2022 | Buy Now | 172.41% | UBS | Elizabeth Garcia71% | → $86 | Initiates | → Sell | Get Alert |
FAQ
What is the target price for QuidelOrtho (QDEL) stock?
The latest price target for QuidelOrtho (NASDAQ:QDEL) was reported by UBS on May 8, 2025. The analyst firm set a price target for $29.00 expecting QDEL to fall to within 12 months (a possible -8.14% downside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for QuidelOrtho (QDEL)?
The latest analyst rating for QuidelOrtho (NASDAQ:QDEL) was provided by UBS, and QuidelOrtho maintained their neutral rating.
When was the last upgrade for QuidelOrtho (QDEL)?
The last upgrade for QuidelOrtho Corp happened on May 8, 2025 when Jefferies raised their price target to $44. Jefferies previously had a hold for QuidelOrtho Corp.
When was the last downgrade for QuidelOrtho (QDEL)?
The last downgrade for QuidelOrtho Corp happened on March 4, 2024 when UBS changed their price target from $70 to $42 for QuidelOrtho Corp.
When is the next analyst rating going to be posted or updated for QuidelOrtho (QDEL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of QuidelOrtho, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for QuidelOrtho was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.
Is the Analyst Rating QuidelOrtho (QDEL) correct?
While ratings are subjective and will change, the latest QuidelOrtho (QDEL) rating was a maintained with a price target of $45.00 to $29.00. The current price QuidelOrtho (QDEL) is trading at is $31.57, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
